Use of Prokinetics in Early Enteral Feeding in Preterm Infants
| Status: | Completed |
|---|---|
| Conditions: | Food Studies |
| Therapuetic Areas: | Pharmacology / Toxicology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/8/2015 |
| Start Date: | October 2011 |
| End Date: | December 2015 |
| Contact: | Darshan d Shah, MD |
| Email: | shahd@etsu.edu |
| Phone: | 423-439-6222 |
Pilot Study for Use of Prokinetics in Early Enteral Feeding of Preterm Infants ; Double Blind; Cross Over Study Comparing Eryththromycin, Metoclopramide and Placebo
Objective of this study are:
1) To determine if medication help extreme preterm infants to tolerate feeding better by
reaching full feeding earlier.2) Out of two medication; which one is better for efficacy 1)
Erythromycin 2) Metoclopramide. Infants who meet inclusion criteria would be entered to
study after parental consent. Infant would be blinded to care givers. Infants will be
randomized to receive one of three medication for 7-14 days. If infants fail on one
medication they will be allowed to crossover to other medication. Infant would be allowed to
treat like other infants. Blindness can be broken if deem necessary by attending
neonatologist.
1) To determine if medication help extreme preterm infants to tolerate feeding better by
reaching full feeding earlier.2) Out of two medication; which one is better for efficacy 1)
Erythromycin 2) Metoclopramide. Infants who meet inclusion criteria would be entered to
study after parental consent. Infant would be blinded to care givers. Infants will be
randomized to receive one of three medication for 7-14 days. If infants fail on one
medication they will be allowed to crossover to other medication. Infant would be allowed to
treat like other infants. Blindness can be broken if deem necessary by attending
neonatologist.
Inclusion Critera:
1. Weight below 1250 grams
2. Age less than 14 days
3. Feeding intolerance; If feeding residual more than 30% on q3 hr feeding; 5 times out of
8 times, feeding residual more than 20% on q4 hr feeding 4 feeding out of 6 feeding or
failure to advance feeding of more than 20ml/kg in 72 hrs.
Exclusion Criteria
1. GI malformation or perforation
2. Genetic disorder
3. Parents can't read English. After consent, if infants meet inclusion criteria, he would
be allowed to receive one of the following three medication. 1) Erythromycin at
1mg/kg/dose q8 hr 2) Metoclopramide 0.1mg/kg/dose q8 hrs and Placebo. If infant fails
to get better, he would be crossover to one of the remaining two.
1. Weight below 1250 grams
2. Age less than 14 days
3. Feeding intolerance; If feeding residual more than 30% on q3 hr feeding; 5 times out of
8 times, feeding residual more than 20% on q4 hr feeding 4 feeding out of 6 feeding or
failure to advance feeding of more than 20ml/kg in 72 hrs.
Exclusion Criteria
1. GI malformation or perforation
2. Genetic disorder
3. Parents can't read English. After consent, if infants meet inclusion criteria, he would
be allowed to receive one of the following three medication. 1) Erythromycin at
1mg/kg/dose q8 hr 2) Metoclopramide 0.1mg/kg/dose q8 hrs and Placebo. If infant fails
to get better, he would be crossover to one of the remaining two.
Inclusion Criteria:
1. Weight below 1250 grams
2. Age less than 14 days
3. Feeding intolerance; If feeding residual more than 30% on q3 hr feeding; 5 times out
of 8 times, feeding residual more than 20% on q4 hr feeding 4 feeding out of 6
feeding or failure to advance feeding of more than 20ml/kg in 72 hrs.
Exclusion Criteria
1. GI malformation or perforation
2. Genetic disorder
3. Parents can't read English. After consent, if infants meet inclusion criteria, he
would be allowed to receive one of the following three medication. 1) Erythromycin at
1mg/kg/dose q8 hr 2) Metoclopramide 0.1mg/kg/dose q8 hrs and Placebo. If infant fails
to get better, he would be crossover to one of the remaining two.
We found this trial at
1
site
Click here to add this to my saved trials
